Industry M&A Weekly: Servier's $2.65B Neurology Bet, Wellington Buys Hartford Funds, and Constellation Takes Finastra's Banking Unit
Four verified deals for the week ending June 8, 2026: Servier acquires Edgewise's muscular dystrophy business for up to $2.65B, Wellington Management buys Hartford Funds for ~$1.9B, Constellation's CORA takes Finastra's US mid-market banking unit, and Sixth Street buys into commodities data firm Kpler at a $3.7B+ valuation. Plus an update on the Uber/Delivery Hero standoff.
Week ending June 8, 2026. Four verified deals across Biotech, Fintech, and data infrastructure — plus the Uber/Delivery Hero standoff entering a new phase.
Loading stats card…
Deal snapshot
| Date | Acquirer | Target | Sector | Value |
|---|---|---|---|---|
| June 1 | Servier | Edgewise Therapeutics muscular dystrophy business | Biotech / Rare neurology | Up to $2.65B |
| June 3 | Wellington Management | Hartford Funds | Fintech / Asset management | ~$1.9B (NPV) |
| June 3 | CORA Group (Constellation Software) | Finastra US mid-market banking unit | Fintech SaaS | Undisclosed (~$200M est.) |
| June 3 | Sixth Street | Kpler minority stake | Data infrastructure / Commodities analytics | $3.7B+ valuation |
Biotech: Servier pays $2.65B for Edgewise's muscular dystrophy pipeline
French pharma Servier agreed on June 1 to acquire the muscular dystrophy business of listed biotech Edgewise Therapeutics for $1.55B upfront, with up to $2.65B in total consideration including regulatory and commercial milestones.1
The deal hands Servier control of sevasemten, an orally dosed fast skeletal myosin inhibitor in a pivotal trial for Becker muscular dystrophy (BMD) and a Phase 2 study in Duchenne — with BMD data expected later this year. Edgewise retains its cardiovascular franchise and will remain a public company.2
The strategic logic is straightforward: Servier is buying a late-stage, non-dystrophin asset that could redefine on-demand treatment in a disease where current options remain thin. Paying $1.55B ahead of pivotal data is a meaningful upfront bet, but the mechanism is differentiated enough — and the BMD commercial window wide enough — that the risk/reward calculation held. It also builds on Servier's growing neurology footprint outside its core oncology and rare-disease base in France.
For Edgewise, the divestiture is effectively a capital unlock. The company was carrying two unrelated franchise areas and a market cap that struggled to reflect either cleanly; now it can focus investment on its cardiovascular lead.
Loading content card…
Fintech: Wellington acquires Hartford Funds in $1.9B asset-management deal
Wellington Management and The Hartford announced on June 3 that Wellington will acquire Hartford Funds, The Hartford's asset management arm, in a deal with an estimated net present value of $1.9B.3
The structure is layered: The Hartford receives $300M upfront, a $170M dividend, and multi-year cash-flow payments that together reach the $1.9B figure. The deal is expected to close in the first quarter of 2027.4
Wellington gets Hartford Funds' distribution infrastructure and brand recognition in the financial-advisor channel — a segment where Wellington has historically been less visible despite managing over $1 trillion for institutional clients. Hartford Funds, which manages roughly $130B in assets, brings retail access and packaged product capabilities that complement Wellington's institutional research engine.
For The Hartford, this is a balance-sheet optimization: the insurer concentrates on property-casualty and group benefits, two businesses with strong 2026 earnings momentum, and converts a non-core asset into a multi-year income stream rather than a lump-sum exit.
Fintech SaaS: Constellation Software takes Finastra's US banking unit through CORA
On June 3, Finastra announced that CORA Group — a software aggregator backed by Constellation Software — had acquired its U.S. mid-market banking business, including the Phoenix Core Banking System, MalauzAi Digital Banking, Analyzer IQ, and Enterprise Content Management.5 The deal price was not disclosed; a market estimate from December 2025 put the unit at $200M or more, implying roughly a 1× revenue multiple.
The acquisition fits CORA's standard operating model: take mission-critical vertical software, give it a permanent home under Constellation's umbrella, and avoid the integration disruption that most acquirers impose. For the hundreds of U.S. community banks and credit unions that run Phoenix, continuity of support matters more than ownership.
Finastra said the move sharpens its focus on lending, payments, and the areas of its platform where it competes globally. Vista Equity-backed Finastra has spent the past two years narrowing its footprint — exiting non-core product lines and investing in open-banking connectors and real-time payments infrastructure.
The deal is a clean illustration of how enterprise software consolidation is functioning in 2026: mid-market legacy systems that are cash-generative but strategically peripheral to large fintech vendors are flowing toward PE-backed aggregators with the appetite and operating model to hold them indefinitely.
Loading content card…
Data infrastructure: Sixth Street buys into Kpler at $3.7B+ valuation
Private credit and equity firm Sixth Street agreed on June 3 to acquire a minority stake in Kpler, a commodities data and intelligence platform, from existing PE owners Insight Partners and Rothschild-owned Five Arrows. The transaction values Kpler at over $3.7B.6
The stake is structured as preferred equity, giving Sixth Street downside protection while preserving upside participation.
Kpler provides real-time intelligence on energy and shipping flows — the kind of proprietary, high-frequency dataset that is increasingly valued as an AI training and inference substrate, not merely a market intelligence product. Buyers are paying premiums for data assets that are both hard to replicate and structurally positioned to benefit from AI-powered analytics demand.
The $3.7B+ valuation implies Kpler has grown substantially from its earlier fundraising rounds and reflects the premium the market assigns to defensible data businesses in commodity-intensive sectors. Sixth Street's entry at this price suggests confidence in Kpler's ability to expand revenue — either through deeper analytics tooling, adjacent energy-transition data products, or geopolitical risk intelligence tied to shipping routes.
Loading content card…
Watch item: Uber/Delivery Hero standoff extends to October
No resolution this week. The European Commission has extended Prosus's deadline to divest its ~17% Delivery Hero stake to October 11 — up from a prior August deadline — buying Prosus time to potentially block or complicate Uber's bid.7 Uber holds a 37% economic stake at a €12B valuation; Delivery Hero's board has not accepted the offer. The situation is now a three-way contest among Uber, Prosus, and Delivery Hero's existing shareholders ahead of Q4.
Themes
1. Rare neurology is the new oncology for bolt-on biotech deals. The Servier/Edgewise transaction continues a pattern that was already evident in Angelini/Catalyst ($4.1B, May) and UCB/Neurona ($1.15B, April): large specialty pharma is paying up for late-stage, mechanism-differentiated rare neurological assets, particularly where the lead program addresses a high-burden disease with no approved oral option. Sevasemten's BMD pivotal data will be the first major read-through for Servier's thesis, and for the sector, this spring.
2. Fintech's incumbents are deconstructing, not consolidating. Both the Wellington/Hartford and Finastra/CORA deals are divestiture-driven: The Hartford exits asset management, Finastra exits community banking. Rather than horizontal consolidation, what's visible is large fintech and financial services companies shedding sub-scale units to sharpen focus. The buyers on the other side — Wellington (adding distribution), CORA (adding mission-critical verticals) — are absorbers, not platform builders.
3. Data assets at infrastructure valuations. Kpler at $3.7B+ is another signal that proprietary, hard-to-replicate data businesses command multiples closer to SaaS infrastructure than to traditional market-data vendors. The premium reflects the AI-substrate narrative: buyers price in the expectation that high-frequency, sector-specific data will have multiple monetization layers as LLM-powered analytics tools proliferate in commodities and energy trading.
References
- 1Fierce Biotech – Servier inks $2.65B buyout
fiercebiotech.com
- 2BioBucks M&A Tracker 2026
biobucks.co
- 3Hartford Funds press release – Wellington to acquire Hartford Funds
hartfordfunds.com
- 4StockTitan – HIG monetizes Hartford Funds
stocktitan.net
- 5
- 6
- 7
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.